לרוש יש תרופה מבטיחה - AI ישראלית תאתר עבורה מטופלים
#Partners
EarlySign Announces Strategic Collaboration Agreement with Roche on AI Solution for Early Detection of Lung Cancer
#Partners
Medial EarlySign signs deal with Roche to develop AI-enabled cancer detection tool
#Partners
Israeli AI-driven early detection solution arms UK health provider with weapon against colon cancer
#Customers #Partners #Expand
Medial EarlySign and Centric Consulting Join Forces to Increase Hospital Adoption of Clinical AI Solutions
#Partners
Health AI Leader Medial EarlySign Launches New Suite of Clinical Data Solutions to Optimize Patient Care
#Customers #Partners
KLAS Research Recognizes Medial EarlySign as Emerging Healthcare AI Company
#Customers
Medial EarlySign, Israeli HMO Maccabi Launch AI Algorithm To Detect High-Risk COVID-19 Cases
#Customers
Maccabi, Medial EarlySign develop algorithm to identify high-risk COVID-19 cases
#Customers
Israeli AI System Helps Save Lives By Flagging Patients At High Risk Of Flu Complications
#Customers #Partners
Predictive Patient Care Startup Medial EarlySign Partners With Israeli HMO on Flu Vaccine Campaign
#Partners
Geisinger and Medial EarlySign Advance to First Stage of CMS AI Health Outcomes Challenge
#Partners
Geisinger partners with EarlySign for AI algorithms to spot chronic disease
#Partners
EarlySign Unveils Commercial Availability of AI Diabetes Risk Predictors Algorithm
#Customers
This Israeli startup aims to catch disease early with data not diagnostic tests
#Customers
SLUCare Selects Medial EarlySign's Artificial Intelligence Tool to Predict Patients at Risk for Lower GI Disorders
#Partners
Medial EarlySign Expands U.S. Footprint With Appointment of Senior Executives
#Customers
Israeli smart software flags patients at risk for colon cancer
#Customers
Medial EarlySign Appoints Chief Medical Officer
#Management Changes
AI tool successfully identifies patients at high risk of CRC in real-world study
#Customers
Medial EarlySign's clinical validation trial shows promise for flagging colorectal cancer patients
#Customers
EarlySign Raises $30M in Series B Funding - FinSMEs
#Investment #Expand
Patient management co Medial EarlySign raises $30m
#Investment
Israeli AI Startup Can Predict Which Diabetes Patients Will Develop Kidney Disease
undefined
Medial EarlySign Named a Gartner Cool Vendor in AI for Healthcare
#Partners
Cool Vendors in AI for Healthcare, 2017
undefined
Medial EarlySign Enables Leading Israeli HMO to Identify Pre-Symptomatic Patients at High Risk for Cancer
#Customers
http://www.israelhayom.com/site/newsletter_article.php?id=25455
undefined